Synopsis
Synopsis
0
JDMF
0
KDMF
0
VMF
0
Australia
0
South Africa
0
US Patents
0
US Exclusivities
0
Health Canada Patents
Annual Reports
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Acetyl Methylprednisolone
2. Acetyl-methylprednisolone
3. Depo Medrol
4. Depo Medrone
5. Depo-medrol
6. Depo-medrone
7. Methylprednisolone 21 Acetate
8. Methylprednisolone Acetate, (11beta,16alpha)-isomer
9. Methylprednisolone Acetate, (11beta,16beta)-isomer
10. Methylprednisolone-21-acetate
1. Depo-medrol
2. 53-36-1
3. M-predrol
4. Depo-medrate
5. Medrol Acetate
6. Depo-medrone
7. Methylprednisolone 21-acetate
8. Depometicort
9. Depomedrone
10. Mepred
11. Medrol Enpak
12. Depo-medrin
13. 6alpha-methylprednisolone Acetate
14. D-med
15. Urbason Crystal Suspension
16. Depo-methylprednisolone Acetate
17. 6alpha-methylprednisolone 21-acetate
18. Depmedalone 40
19. Depmedalone 80
20. Methyl Prednisolone Acetate
21. U 8210
22. 11beta,17,21-trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 21-acetate
23. Nsc-48985
24. 6alpha-methyl Prednisolone 21-acetate
25. Chebi:6889
26. Nsc 48985
27. 43502p7f0p
28. Depo-methylprednisolone
29. Unidrol
30. Lemod Depo
31. (6alpha,11beta)-11,17-dihydroxy-6-methyl-3,20-dioxopregna-1,4-dien-21-yl Acetate
32. Solsolona [inj.]
33. Ubrason [inj.]
34. [2-[(6s,8s,9s,10r,11s,13s,14s,17r)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] Acetate
35. Depot-medrol
36. Solsolona
37. Ubrason
38. Mls002667229
39. Einecs 200-171-3
40. 6-methylprednisolone Acetate
41. 6.alpha.-methylprednisolone Acetate
42. Unii-43502p7f0p
43. 6.alpha.-methylprednisolone 21-acetate
44. Ncgc00159503-02
45. Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-11,17-dihydroxy-6-methyl-, (6.alpha.,11.beta.)-
46. Depo-medrol (tn)
47. Methylprednisolone Acetate [usp:jan]
48. Component Of Neo-medrol
49. Dsstox_cid_3302
50. Methylprednisolon-21-acetat
51. Dsstox_rid_76966
52. Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-11,17-dihydroxy-6-methyl-, (6-alpha,11-beta)-
53. Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-11,17-dihydroxy-6-methyl-, (6alpha,11beta)-
54. Dsstox_gsid_23302
55. Schembl13231
56. Mls001304003
57. Methyl Prednisolone 21-acetate
58. Chembl1364144
59. Dtxsid7023302
60. Methylprednisolone Ep Impurity J
61. 11.beta.,17,21-trihydroxy-6.alpha.-methylpregna-1,4-diene-3,20-dione 21-acetate
62. Bdbm233194
63. Hms2233n14
64. Hms3259l07
65. Nsc48985
66. 6?-methyl Prednisolone 21-acetate
67. Tox21_111722
68. S5973
69. Methylprednisolone Acetate (jan/usp)
70. Akos015969745
71. Zinc118912449
72. Nc00628
73. 6 Alpha -methylprednisolone 21-acetate
74. Cas-53-36-1
75. Methylprednisolone Acetate [jan]
76. Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl-, 21-acetate
77. Hy-13681
78. Methylprednisolone Acetate [mart.]
79. Methylprednisolone Acetate [vandf]
80. Smr000718757
81. Methylprednisolone Acetate [usp-rs]
82. Methylprednisolone Acetate [who-dd]
83. Cs-0007549
84. M2635
85. C08179
86. D00979
87. D87728
88. Methylprednisolone Acetate [green Book]
89. Methylprednisolone Acetate [orange Book]
90. Ab00375925-05
91. Methylprednisolone Acetate [ep Monograph]
92. Methylprednisolone Acetate [usp Impurity]
93. Methylprednisolone Acetate For Peak Identification
94. Methylprednisolone Acetate For System Suitability
95. 200m356
96. Methylprednisolone Acetate [usp Monograph]
97. Methylprednisolone Impurity J [ep Impurity]
98. Methylprednisolone Acetate 100 Microg/ml In Methanol
99. Q27107351
100. Neo-medrol Acetate Component Methylprednisolone Acetate
101. Methylprednisolone Acetate Component Of Neo-medrol Acetate
102. Methylprednisolone Hydrogen Succinate Impurity C [ep Impurity]
103. Pregna-1,20-dione, 11.beta.,17,21-trihydroxy-6.alpha.-methyl-, 21-acetate
104. Pregna-1,20-dione, 21-(acetyloxy)-11,17-dihydroxy-6-methyl-, (6.alpha.,11.beta.)-
105. Methylprednisolone Acetate; 6?-methyl Prednisolone 21-acetate; Methylprednisolone Hydrogen Succinate Ep Impurity C; 11?,17-dihydroxy-6?-methyl-3,20-dioxopregna-1,4-dien21-yl Acetate; 21-acetoxy-11?,17-dihydroxy-6?-methylpregna-1,4-diene-3,20-dione
Molecular Weight | 416.5 g/mol |
---|---|
Molecular Formula | C24H32O6 |
XLogP3 | 2.7 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 4 |
Exact Mass | 416.21988874 g/mol |
Monoisotopic Mass | 416.21988874 g/mol |
Topological Polar Surface Area | 101 Ų |
Heavy Atom Count | 30 |
Formal Charge | 0 |
Complexity | 858 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 8 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
1 of 4 | |
---|---|
Drug Name | Depo-medrol |
Drug Label | DEPO-MEDROL is an anti-inflammatory glucocorticoid for intramuscular, intra-articular, soft tissue, or intralesional injection. It is available in three strengths: 20 mg/mL; 40 mg/mL; 80 mg/mL.Each mL of these preparations contains:Methylprednisolone... |
Active Ingredient | Methylprednisolone acetate |
Dosage Form | Injectable |
Route | Injection |
Strength | 20mg/ml; 80mg/ml; 40mg/ml |
Market Status | Prescription |
Company | Pharmacia And Upjohn |
2 of 4 | |
---|---|
Drug Name | Methylprednisolone acetate |
Drug Label | DEPO-MEDROL is an anti-inflammatory glucocorticoid for intramuscular, intra-articular, soft tissue, or intralesional injection. It is available in three strengths: 20 mg/mL; 40 mg/mL; 80 mg/mL.Each mL of these preparations contains:Methylprednisolone... |
Active Ingredient | Methylprednisolone acetate |
Dosage Form | Injectable |
Route | Injection |
Strength | 80mg/ml; 40mg/ml |
Market Status | Prescription |
Company | Teva Pharms Usa; Sandoz |
3 of 4 | |
---|---|
Drug Name | Depo-medrol |
Drug Label | DEPO-MEDROL is an anti-inflammatory glucocorticoid for intramuscular, intra-articular, soft tissue, or intralesional injection. It is available in three strengths: 20 mg/mL; 40 mg/mL; 80 mg/mL.Each mL of these preparations contains:Methylprednisolone... |
Active Ingredient | Methylprednisolone acetate |
Dosage Form | Injectable |
Route | Injection |
Strength | 20mg/ml; 80mg/ml; 40mg/ml |
Market Status | Prescription |
Company | Pharmacia And Upjohn |
4 of 4 | |
---|---|
Drug Name | Methylprednisolone acetate |
Drug Label | DEPO-MEDROL is an anti-inflammatory glucocorticoid for intramuscular, intra-articular, soft tissue, or intralesional injection. It is available in three strengths: 20 mg/mL; 40 mg/mL; 80 mg/mL.Each mL of these preparations contains:Methylprednisolone... |
Active Ingredient | Methylprednisolone acetate |
Dosage Form | Injectable |
Route | Injection |
Strength | 80mg/ml; 40mg/ml |
Market Status | Prescription |
Company | Teva Pharms Usa; Sandoz |
Anti-Inflammatory Agents
Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
41
PharmaCompass offers a list of Methylprednisolone Acetate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Methylprednisolone Acetate manufacturer or Methylprednisolone Acetate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Methylprednisolone Acetate manufacturer or Methylprednisolone Acetate supplier.
PharmaCompass also assists you with knowing the Methylprednisolone Acetate API Price utilized in the formulation of products. Methylprednisolone Acetate API Price is not always fixed or binding as the Methylprednisolone Acetate Price is obtained through a variety of data sources. The Methylprednisolone Acetate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A DSSTox_CID_3302 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of DSSTox_CID_3302, including repackagers and relabelers. The FDA regulates DSSTox_CID_3302 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. DSSTox_CID_3302 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of DSSTox_CID_3302 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A DSSTox_CID_3302 supplier is an individual or a company that provides DSSTox_CID_3302 active pharmaceutical ingredient (API) or DSSTox_CID_3302 finished formulations upon request. The DSSTox_CID_3302 suppliers may include DSSTox_CID_3302 API manufacturers, exporters, distributors and traders.
click here to find a list of DSSTox_CID_3302 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A DSSTox_CID_3302 DMF (Drug Master File) is a document detailing the whole manufacturing process of DSSTox_CID_3302 active pharmaceutical ingredient (API) in detail. Different forms of DSSTox_CID_3302 DMFs exist exist since differing nations have different regulations, such as DSSTox_CID_3302 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A DSSTox_CID_3302 DMF submitted to regulatory agencies in the US is known as a USDMF. DSSTox_CID_3302 USDMF includes data on DSSTox_CID_3302's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The DSSTox_CID_3302 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of DSSTox_CID_3302 suppliers with USDMF on PharmaCompass.
A DSSTox_CID_3302 CEP of the European Pharmacopoeia monograph is often referred to as a DSSTox_CID_3302 Certificate of Suitability (COS). The purpose of a DSSTox_CID_3302 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of DSSTox_CID_3302 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of DSSTox_CID_3302 to their clients by showing that a DSSTox_CID_3302 CEP has been issued for it. The manufacturer submits a DSSTox_CID_3302 CEP (COS) as part of the market authorization procedure, and it takes on the role of a DSSTox_CID_3302 CEP holder for the record. Additionally, the data presented in the DSSTox_CID_3302 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the DSSTox_CID_3302 DMF.
A DSSTox_CID_3302 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. DSSTox_CID_3302 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of DSSTox_CID_3302 suppliers with CEP (COS) on PharmaCompass.
A DSSTox_CID_3302 written confirmation (DSSTox_CID_3302 WC) is an official document issued by a regulatory agency to a DSSTox_CID_3302 manufacturer, verifying that the manufacturing facility of a DSSTox_CID_3302 active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting DSSTox_CID_3302 APIs or DSSTox_CID_3302 finished pharmaceutical products to another nation, regulatory agencies frequently require a DSSTox_CID_3302 WC (written confirmation) as part of the regulatory process.
click here to find a list of DSSTox_CID_3302 suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing DSSTox_CID_3302 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for DSSTox_CID_3302 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture DSSTox_CID_3302 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain DSSTox_CID_3302 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a DSSTox_CID_3302 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of DSSTox_CID_3302 suppliers with NDC on PharmaCompass.
DSSTox_CID_3302 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of DSSTox_CID_3302 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right DSSTox_CID_3302 GMP manufacturer or DSSTox_CID_3302 GMP API supplier for your needs.
A DSSTox_CID_3302 CoA (Certificate of Analysis) is a formal document that attests to DSSTox_CID_3302's compliance with DSSTox_CID_3302 specifications and serves as a tool for batch-level quality control.
DSSTox_CID_3302 CoA mostly includes findings from lab analyses of a specific batch. For each DSSTox_CID_3302 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
DSSTox_CID_3302 may be tested according to a variety of international standards, such as European Pharmacopoeia (DSSTox_CID_3302 EP), DSSTox_CID_3302 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (DSSTox_CID_3302 USP).